Fraud Prosecution Against Device Industry Is Pharma “Spill-Over” – Attorney
This article was originally published in The Gray Sheet
Executive Summary
The HHS Office of Inspector General is ramping up fraud prosecution against high-level managers at medical device companies, according to Arnold & Porter Partner John Bentivoglio
You may also be interested in...
Ethics Code Adopted By Industry; DoJ Launches Medtronic Kickback Probe
Improper inducements to physicians during sales events, including meals for spouses/guests, overstep mere business courtesies and should be discouraged, according to AdvaMed's revised "1Code of Ethics for Interactions With Health Care Professionals.
Abbott Corporate Integrity Pact Ratchets-Up Scrutiny Of Nutrition Pump Sales
Abbott's Ross Products unit will retain an independent review organization to oversee sales and marketing of enteral nutritional pumps and related disposables under a 1corporate integrity agreement between Abbott and the HHS Office of Inspector General
Pink Sheet Podcast: Leqembi Spending, Woodcock’s Next Act, Pneumococcal Vaccine Development
Pink Sheet editors discuss Medicare spending projections for the Alzheimer’s treatment Leqembi, Janet Woodcock’s new post-FDA role, and ongoing preparations for new pneumococcal vaccines that will reach the market soon.